Serum β-hCG as an Indicator of Recurrence After the Complete Resection of a Malignant Solitary Fibrous Tumor of the Pleura.
Serum β-hCG as an Indicator of Recurrence After the Complete Resection of a Malignant Solitary Fibrous Tumor of the Pleura.
复制标题
血清 β-hCG 作为胸膜恶性孤立性纤维瘤完全切除后复发的指标。
DOI：
10.1016/j.athoracsur.2016.05.061
复制
发表时间：
2016
期刊：
影响因子：
4.6
通讯作者：
Okada Y.
中科院分区：
文献类型：
--
作者：
Yabuki H;Sakurada A;Niikawa H;Notsuda H;Endo C;Matsuda Y;Noda M;Saito R;Yamashita S;Arai Y;Okada Y.
在胸膜孤立性纤维瘤（SFT），恶性SFT是罕见的。尽管已知SFT通过产生胰岛素样生长因子引起副肿瘤综合征，但据我们所知，仅在1例良性SFT患者中报告了β-人绒毛膜促性腺激素（β-hCG）的产生。我们在此报告了第一例与恶性SFT相关的血清β-hCG水平升高的病例，其中血清β-hCG水平成为原发性纵隔病变完全切除后复发的有用指标。
In solitary fibrous tumors (SFTs) of the pleura, malignant SFTs are uncommon. Although SFTs are known to cause paraneoplastic syndromes through the production of insulin-like growth factor, to the best of our knowledge, the production of beta-human chorionic gonadotropin (β-hCG) has been reported only in 1 case involving a patient with a benign SFT. We herein report the first case of the elevation of β-hCG serum levels associated with a malignant SFT in which the β-hCG serum level became a useful indicator of recurrence after the complete resection of the primary mediastinal lesion.